Selenium Not Protecting Men From Getting Prostate Cancer?

The Center for Science in the Public Interest has stated it will file a suit against Bayer HealthCare, alleging "deceptive and irresponsible" advertising indicating selenium may reduce men's risk of prostate cancer, despite the findings of a large research study funded by the National Institutes of Health stating selenium does not prevent prostate cancer in healthy men. One A Day Men's 50+ Advantage ads say selenium may cut men's risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial, which involved 35,000 U.S. and Canadian men, was halted in October 2008 when researchers determined selenium was not protecting the men from prostate cancer and may even cause diabetes.
In support of the center's letter of complaint to the Federal Trade Commission (FTC), nine researchers including signees from the American Cancer Society and Harvard School of Public Health wrote directly to Bayer's associate director of advertising practices. Their letter supporting the FTC's complaint states, "the federally financed study was the largest individually, randomized cancer prevention trial ever conducted, and, given its high rates of adherence and its statistical power, it is unlikely to have missed detecting a benefit of even a very modest size."

More federal funds going down the ole tube.

Have a good weekend.
Blessings,
Rick